PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
 
Environ Health Perspect. 1997 October; 105(10): 1116–1124.
PMCID: PMC1470374
Research Article

Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species.

Abstract

The recognition of adverse effects due to environmental endocrine disruptors in humans and wildlife has focused attention on the need for predictive tools to select the most likely estrogenic chemicals from a very large number of chemicals for subsequent screening and/or testing for potential environmental toxicity. A three-dimensional quantitative structure-activity relationship (QSAR) model using comparative molecular field analysis (CoMFA) was constructed based on relative binding affinity (RBA) data from an estrogen receptor (ER) binding assay using calf uterine cytosol. The model demonstrated significant correlation of the calculated steric and electrostatic fields with RBA and yielded predictions that agreed well with experimental values over the entire range of RBA values. Analysis of the CoMFA three-dimensional contour plots revealed a consistent picture of the structural features that are largely responsible for the observed variations in RBA. Importantly, we established a correlation between the predicted RBA values for calf ER and their actual RBA values for human ER. These findings suggest a means to begin to construct a more comprehensive estrogen knowledge base by combining RBA assay data from multiple species in 3D-QSAR based predictive models, which could then be used to screen untested chemicals for their potential to bind to the ER. Another QSAR model was developed based on classical physicochemical descriptors generated using the CODESSA (Comprehensive Descriptors for Structural and Statistical Analysis) program. The predictive ability of the CoMFA model was superior to the corresponding CODESSA model.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mishell DR., Jr Noncontraceptive benefits of oral contraceptives. J Reprod Med. 1993 Dec;38(12 Suppl):1021–1029. [PubMed]
  • Barrett-Connor E. Risks and benefits of replacement estrogen. Annu Rev Med. 1992;43:239–251. [PubMed]
  • Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 1993 Oct;101(5):378–384. [PMC free article] [PubMed]
  • Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect. 1996 Aug;104 (Suppl 4):715–740. [PMC free article] [PubMed]
  • Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993 Oct;101(5):372–377. [PMC free article] [PubMed]
  • Katzenellenbogen JA. The structural pervasiveness of estrogenic activity. Environ Health Perspect. 1995 Oct;103 (Suppl 7):99–101. [PMC free article] [PubMed]
  • Korach KS, McLachlan JA. Techniques for detection of estrogenicity. Environ Health Perspect. 1995 Oct;103 (Suppl 7):5–8. [PMC free article] [PubMed]
  • Branham WS, Zehr DR, Sheehan DM. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med. 1993 Jul;203(3):297–303. [PubMed]
  • Medlock KL, Branham WS, Sheehan DM. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc Soc Exp Biol Med. 1995 Jan;208(1):67–71. [PubMed]
  • Miksicek RJ. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med. 1995 Jan;208(1):44–50. [PubMed]
  • Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995 Oct;103 (Suppl 7):113–122. [PMC free article] [PubMed]
  • Liskowski L, Rose DP. Experience with a simple method for estrogen receptor assay in breast cancer. Clin Chim Acta. 1976 Mar 1;67(2):175–182. [PubMed]
  • Anstead GM, Carlson KE, Katzenellenbogen JA. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids. 1997 Mar;62(3):268–303. [PubMed]
  • Bradbury SP. Quantitative structure-activity relationships and ecological risk assessment: an overview of predictive aquatic toxicology research. Toxicol Lett. 1995 Sep;79(1-3):229–237. [PubMed]
  • Hansch C, Telzer BR, Zhang L. Comparative QSAR in toxicology: examples from teratology and cancer chemotherapy of aniline mustards. Crit Rev Toxicol. 1995;25(1):67–89. [PubMed]
  • Collantes ER, Tong W, Weish WJ, Zielinski WL. Use of moment of inertia in comparative molecular field analysis to model chromatographic retention of nonpolar solutes. Anal Chem. 1996 Jul 1;68(13):2038–2043. [PubMed]
  • Waller CL, Minor DL, McKinney JD. Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxybiphenyls. Environ Health Perspect. 1995 Jul-Aug;103(7-8):702–707. [PMC free article] [PubMed]
  • Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE., Jr Ligand-based identification of environmental estrogens. Chem Res Toxicol. 1996 Dec;9(8):1240–1248. [PubMed]
  • Gantchev TG, Ali H, van Lier JE. Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives. J Med Chem. 1994 Nov 25;37(24):4164–4176. [PubMed]
  • Tong W, Perkins R, Xing L, Welsh WJ, Sheehan DM. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Endocrinology. 1997 Sep;138(9):4022–4025. [PubMed]
  • Loughney DA, Schwender CF. A comparison of progestin and androgen receptor binding using the CoMFA technique. J Comput Aided Mol Des. 1992 Dec;6(6):569–581. [PubMed]
  • Oprea TI, García AE. Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors. J Comput Aided Mol Des. 1996 Jun;10(3):186–200. [PubMed]
  • Waller CL, Juma BW, Gray LE, Jr, Kelce WR. Three-dimensional quantitative structure--activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol. 1996 Apr;137(2):219–227. [PubMed]
  • von Angerer E, Prekajac J, Strohmeier J. 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. J Med Chem. 1984 Nov;27(11):1439–1447. [PubMed]
  • Polossek T, Ambros R, von Angerer S, Brandl G, Mannschreck A, von Angerer E. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity. J Med Chem. 1992 Sep 18;35(19):3537–3547. [PubMed]
  • von Angerer E, Biberger C, Holler E, Koop R, Leichtl S. 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism. J Steroid Biochem Mol Biol. 1994 May;49(1):51–62. [PubMed]
  • VanderKuur JA, Wiese T, Brooks SC. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry. 1993 Jul 13;32(27):7002–7008. [PubMed]
  • Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. [PubMed]
  • Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986 Mar 13;320(6058):134–139. [PubMed]
  • Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986 Mar 7;231(4742):1150–1154. [PubMed]
  • Sheehan DM, Branham WS. Dissociation of estrogen-induced uterine growth and ornithine decarboxylase activity in the postnatal rat. Teratog Carcinog Mutagen. 1987;7(4):411–422. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science